View more in
Cancer

Evolving Treatment Options for Relapsed/Refractory Multiple Myeloma

onclive.com
 2021-06-11

Cover picture for the articleDrs Hoffman and Richter discuss a promising new treatment for patients with relapsed/refractory multiple myeloma who are not eligible for a clinical trial after 4 lines of therapy. James Hoffman, MD: We’ll see if we agree on this one. We’ve got to find some controversy here, perhaps. I’m always, and...

www.onclive.com

Comments / 0

Comments / 0